Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
about
Studies on anticancer activities of antimicrobial peptidesTethered and Polymer Supported Bilayer Lipid Membranes: Structure and FunctionFunctions of Cationic Host Defense Peptides in ImmunityMechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin DOn the role of NMR spectroscopy for characterization of antimicrobial peptidesThe magic of bicelles lights up membrane protein structureAntimicrobial peptides: their role as infection-selective tracers for molecular imagingAntimicrobial peptides in 2014Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo CathelicidinsStructures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micellesHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Antimicrobial Peptides Targeting Gram-Positive BacteriaThe antimicrobial activity of gramicidin A is associated with hydroxyl radical formationOn the performance of spin diffusion NMR techniques in oriented solids: prospects for resonance assignments and distance measurements from separated local field experiments.Antimicrobial peptides temporins B and L induce formation of tubular lipid protrusions from supported phospholipid bilayersReal-time attack of LL-37 on single Bacillus subtilis cells.Imaging the antimicrobial mechanism(s) of cathelicidin-2.Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groupsInduction of morphological changes in model lipid membranes and the mechanism of membrane disruption by a large scorpion-derived pore-forming peptide.Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective bindingNMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles.Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins.Freezing point depression of water in phospholipid membranes: a solid-state NMR study.NMR structure of a viral peptide inserted in artificial membranes: a view on the early steps of the birnavirus entry processVariations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killingAntimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37Flagellin delivery by Pseudomonas aeruginosa rhamnolipids induces the antimicrobial protein psoriasin in human skin.Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.Investigating structural changes in the lipid bilayer upon insertion of the transmembrane domain of the membrane-bound protein phospholamban utilizing 31P and 2H solid-state NMR spectroscopyMelittin-induced bilayer leakage depends on lipid material properties: evidence for toroidal pores.Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers.Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaSolid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin.FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells.Transmembrane pores formed by human antimicrobial peptide LL-37.Activity determinants of helical antimicrobial peptides: a large-scale computational studyA bovine myeloid antimicrobial peptide (BMAP-28) kills methicillin-resistant Staphylococcus aureus but promotes adherence of the bacteria.Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy.Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy
P2860
Q24650885-5EB5F6A4-9F1E-414C-B7CD-D3E5A499DD48Q26744191-E59A5059-A7C1-4AD7-9562-2FC8CD483F72Q26744224-37E0087B-E739-4DAF-8B97-DC363981EF35Q26781318-3F28F3ED-8160-4C9B-830C-E5CAD803EAE8Q26830116-D30100D5-9A48-4906-8E2C-33DCC7F83700Q26991483-64F06123-A343-4667-9162-BDB815E3004EQ27014021-321747F4-AFE1-4B36-92BB-90D5E84FDC48Q27027316-19687115-AE88-48E5-A54C-5AEC7474500AQ27335293-29DDF56A-CEF4-4D61-A30F-D2021F1925C8Q27652293-A76BC590-D661-435E-9611-BB18F52638F0Q27692605-08DE2972-A6D9-416F-9C75-B0BB41BBAF06Q28077888-4E237396-7FBF-479E-9054-2FD6F6959D80Q28543097-4A49BA58-5473-4E84-AF1E-05599930E13AQ30394749-9C6BFB19-5A92-4E7E-8840-C3696B76D64BQ30478852-EC882A12-5D34-472E-B586-58A953FE1039Q30538846-87F89053-9ADB-4883-A309-54E4CD91FBF3Q30810976-D5498B10-F0C6-4538-AAD5-DAE2EBC7A3A5Q30831776-F13F5C50-627C-4630-ADE3-9F66C5C5DB2EQ31008813-5262320F-8615-406C-9BEC-E720FFDDFC18Q31040674-188A5BE5-5221-43ED-AAE9-EAD6CB10ABC4Q31153718-D78D186A-AB8E-4B04-B6E0-09790B180DC7Q33268976-9ED2F37A-8EE8-487F-A20D-C4C835CB50EBQ33383345-6243DF8F-BCDB-467C-93BD-8229495EDEA4Q33552978-8A2FB5E6-257D-4851-B0CD-66F0CBCA52B6Q33579842-E17CD0DD-0F6B-47A0-B960-8CAD90A0F193Q33598932-4023B3EC-3E09-4E0E-973E-716B665BA553Q33808611-6CD72E33-A057-451C-87D9-36662FB73849Q33999607-A8A77479-F8C2-43D3-B4DF-F10AF7AE087EQ34185000-B9808A14-AE5D-4EF0-91B5-F6C8C370E299Q34189385-10287531-04F7-4A4B-B481-74F73B037BABQ34352478-0E1F54E1-8024-46B5-9BD5-453A92D27748Q34354107-EDB47932-6FB0-4E7A-939F-D2A0387E645AQ34647328-7DF1E9C6-BE56-4999-9CCD-18D057389DD5Q34680351-F5B5E6A8-769C-4CFA-818B-5136E3C78E6CQ34735130-334A7C2B-ABCE-4BBF-8FFB-10FDC185C980Q34771808-538B746F-2F20-479A-96FB-0FAEEB7CF7BDQ34776684-B8FF719B-DDB4-45A6-A6A4-3F37BEBE05D8Q34974932-4E1F6E91-6EF1-43C9-9697-FE3FD07E5AF5Q35058826-C2F34EED-E8C0-4412-B35A-8B2AB8301494Q35269863-91E2E208-F7B4-433B-8911-C5922CB56B1A
P2860
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@ast
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@en
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@nl
type
label
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@ast
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@en
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@nl
prefLabel
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@ast
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@en
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@nl
P356
P1433
P1476
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
@en
P2093
Dong-Kuk Lee
Katherine A Henzler Wildman
P304
P356
10.1021/BI0273563
P407
P577
2003-06-01T00:00:00Z